Hisamitsu Pharmaceutical Co Inc
TSE:4530

Watchlist Manager
Hisamitsu Pharmaceutical Co Inc Logo
Hisamitsu Pharmaceutical Co Inc
TSE:4530
Watchlist
Price: 4 100 JPY -0.46% Market Closed
Market Cap: 318.7B JPY
Have any thoughts about
Hisamitsu Pharmaceutical Co Inc?
Write Note

Intrinsic Value

The intrinsic value of one Hisamitsu Pharmaceutical Co Inc stock under the Base Case scenario is 4 348.76 JPY. Compared to the current market price of 4 100 JPY, Hisamitsu Pharmaceutical Co Inc is Undervalued by 6%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
4 348.76 JPY
Undervaluation 6%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Hisamitsu Pharmaceutical Co Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for Hisamitsu Pharmaceutical Co Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Hisamitsu Pharmaceutical Co Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

4 100 JPY
-0.46%
-0.46%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Hisamitsu Pharmaceutical Co Inc
JP
Pharmaceuticals
Market Cap
300.7B JPY
IPO
Sep 1, 1962
Employees
2 770
Japan
Market Cap
300.7B JPY
Industry
Pharmaceuticals
IPO
Sep 1, 1962
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Hisamitsu Pharmaceutical Co Inc

Provide an overview of the primary business activities
of Hisamitsu Pharmaceutical Co Inc.

What unique competitive advantages
does Hisamitsu Pharmaceutical Co Inc hold over its rivals?

What risks and challenges
does Hisamitsu Pharmaceutical Co Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Hisamitsu Pharmaceutical Co Inc.

Provide P/S
for Hisamitsu Pharmaceutical Co Inc.

Provide P/E
for Hisamitsu Pharmaceutical Co Inc.

Provide P/OCF
for Hisamitsu Pharmaceutical Co Inc.

Provide P/FCFE
for Hisamitsu Pharmaceutical Co Inc.

Provide P/B
for Hisamitsu Pharmaceutical Co Inc.

Provide EV/S
for Hisamitsu Pharmaceutical Co Inc.

Provide EV/GP
for Hisamitsu Pharmaceutical Co Inc.

Provide EV/EBITDA
for Hisamitsu Pharmaceutical Co Inc.

Provide EV/EBIT
for Hisamitsu Pharmaceutical Co Inc.

Provide EV/OCF
for Hisamitsu Pharmaceutical Co Inc.

Provide EV/FCFF
for Hisamitsu Pharmaceutical Co Inc.

Provide EV/IC
for Hisamitsu Pharmaceutical Co Inc.

Show me price targets
for Hisamitsu Pharmaceutical Co Inc made by professional analysts.

What are the Revenue projections
for Hisamitsu Pharmaceutical Co Inc?

How accurate were the past Revenue estimates
for Hisamitsu Pharmaceutical Co Inc?

What are the Net Income projections
for Hisamitsu Pharmaceutical Co Inc?

How accurate were the past Net Income estimates
for Hisamitsu Pharmaceutical Co Inc?

What are the EPS projections
for Hisamitsu Pharmaceutical Co Inc?

How accurate were the past EPS estimates
for Hisamitsu Pharmaceutical Co Inc?

What are the EBIT projections
for Hisamitsu Pharmaceutical Co Inc?

How accurate were the past EBIT estimates
for Hisamitsu Pharmaceutical Co Inc?

Compare the revenue forecasts
for Hisamitsu Pharmaceutical Co Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Hisamitsu Pharmaceutical Co Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Hisamitsu Pharmaceutical Co Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Hisamitsu Pharmaceutical Co Inc compared to its peers.

Compare the P/E ratios
of Hisamitsu Pharmaceutical Co Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Hisamitsu Pharmaceutical Co Inc with its peers.

Analyze the financial leverage
of Hisamitsu Pharmaceutical Co Inc compared to its main competitors.

Show all profitability ratios
for Hisamitsu Pharmaceutical Co Inc.

Provide ROE
for Hisamitsu Pharmaceutical Co Inc.

Provide ROA
for Hisamitsu Pharmaceutical Co Inc.

Provide ROIC
for Hisamitsu Pharmaceutical Co Inc.

Provide ROCE
for Hisamitsu Pharmaceutical Co Inc.

Provide Gross Margin
for Hisamitsu Pharmaceutical Co Inc.

Provide Operating Margin
for Hisamitsu Pharmaceutical Co Inc.

Provide Net Margin
for Hisamitsu Pharmaceutical Co Inc.

Provide FCF Margin
for Hisamitsu Pharmaceutical Co Inc.

Show all solvency ratios
for Hisamitsu Pharmaceutical Co Inc.

Provide D/E Ratio
for Hisamitsu Pharmaceutical Co Inc.

Provide D/A Ratio
for Hisamitsu Pharmaceutical Co Inc.

Provide Interest Coverage Ratio
for Hisamitsu Pharmaceutical Co Inc.

Provide Altman Z-Score Ratio
for Hisamitsu Pharmaceutical Co Inc.

Provide Quick Ratio
for Hisamitsu Pharmaceutical Co Inc.

Provide Current Ratio
for Hisamitsu Pharmaceutical Co Inc.

Provide Cash Ratio
for Hisamitsu Pharmaceutical Co Inc.

What is the historical Revenue growth
over the last 5 years for Hisamitsu Pharmaceutical Co Inc?

What is the historical Net Income growth
over the last 5 years for Hisamitsu Pharmaceutical Co Inc?

What is the current Free Cash Flow
of Hisamitsu Pharmaceutical Co Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Hisamitsu Pharmaceutical Co Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hisamitsu Pharmaceutical Co Inc

Current Assets 207B
Cash & Short-Term Investments 122.7B
Receivables 51.6B
Other Current Assets 32.7B
Non-Current Assets 143.4B
Long-Term Investments 65.7B
PP&E 58.8B
Intangibles 6.5B
Other Non-Current Assets 12.4B
Current Liabilities 58.6B
Accounts Payable 22.1B
Accrued Liabilities 1.3B
Other Current Liabilities 35.2B
Non-Current Liabilities 18.3B
Long-Term Debt 46m
Other Non-Current Liabilities 18.3B
Efficiency

Earnings Waterfall
Hisamitsu Pharmaceutical Co Inc

Revenue
150.2B JPY
Cost of Revenue
-65.5B JPY
Gross Profit
84.7B JPY
Operating Expenses
-71.8B JPY
Operating Income
12.9B JPY
Other Expenses
1.7B JPY
Net Income
14.7B JPY

Free Cash Flow Analysis
Hisamitsu Pharmaceutical Co Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hisamitsu Pharmaceutical Co Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
52/100
Profitability
Score

Hisamitsu Pharmaceutical Co Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hisamitsu Pharmaceutical Co Inc's solvency score is 94/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Long-Term Solvency
Negative Net Debt
Low D/E
94/100
Solvency
Score

Hisamitsu Pharmaceutical Co Inc's solvency score is 94/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hisamitsu Pharmaceutical Co Inc

Wall Street analysts forecast Hisamitsu Pharmaceutical Co Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hisamitsu Pharmaceutical Co Inc is 4 590 JPY with a low forecast of 4 545 JPY and a high forecast of 4 725 JPY.

Lowest
Price Target
4 545 JPY
11% Upside
Average
Price Target
4 590 JPY
12% Upside
Highest
Price Target
4 725 JPY
15% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Hisamitsu Pharmaceutical Co Inc?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hisamitsu Pharmaceutical Co Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Hisamitsu Pharmaceutical Co Inc stock?

The intrinsic value of one Hisamitsu Pharmaceutical Co Inc stock under the Base Case scenario is 4 348.76 JPY.

Is Hisamitsu Pharmaceutical Co Inc stock undervalued or overvalued?

Compared to the current market price of 4 100 JPY, Hisamitsu Pharmaceutical Co Inc is Undervalued by 6%.

Back to Top